10.3389/fpsyt.2022.1070456 45
Improved Muscle building potential Increased endurance, Strength and stamina Improved bone strength Reduced risk of overtraining Improved mental function Improved Fat metabolism Increased muscle mass Reduced recovery times Improved energy levels Increased male fertility Other Ingredients: Water, Malic Acid, citric Acid, Flavourings,Potassium sorbate, Sodium Benzoate, Acessulfame K,Suralose, Steviol Glycosides Direction Of Use: Consume 30minutes to an hour prior to exercise and/or between meals Specifications: Brand - Muscle Core Type - Protein Powder Product Weight - 60ml Items Included in the Package: 12 Pieces of Protein Powder Product ID:47e4bae68a0a4 Read more Questions & Answers Your Question has been sucessfully submitted
The products ability to initiate the transport of fatty acids into the mitochondria for energy production has established it as a preferred ingredient, particularly in sports nutrition and weight management products
Abbreviations ADA Adenosine deaminase ADVANCE Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation Afib Atrial fibrillation BNP Brain natriuretic peptide cAMP Cyclic adenosine 3,5-monophosphate CI Confidence interval CKD Chronic kidney disease CVD Cardiovascular disease CVOTs Cardiovascular outcome trials DPP-4 Dipeptidyl peptidase-4 DPP-4i DPP-4 inhibitor eGFR Estimated glomerular filtration rate FDA Food and Drug Administration GAS Interferon-gamma-activated sequence GIP Glucose-dependent insulinotropic polypeptide GLP-1 Glucagon-like peptide-1 GLP-1R GLP-1 receptor GLP-1RAs Glucagon-like peptide-1 receptor agonists HbA1c Glycated hemoglobin HDL High-density lipoprotein HF Heart failure HNF-1 Hepatocyte nuclear factor-1 HR Hazard ratio hs-CRP High-sensitivity C-reactive protein IL-12 Interleukin-12 IVUS Intravascular ultrasound LDL Low-density lipoprotein LVEF Left ventricular ejection fraction MACE Major adverse cardiovascular events MI Myocardial infarction MMPs Matrix metalloproteases PAI-1 Plasminogen activator inhibitor-1 PCI Percutaneous coronary intervention PKA Protein kinase A PWV Pulse wave velocity SGLT-2i Sodium/glucose cotransporter-2 inhibitors STAT1 Signal transducer and activator of transcription 1 T1DM Type 1 diabetes mellitus T2DM Type 2 diabetes mellitus TGF- Transforming growth factor- TLR4 Toll-like receptor 4 TNF- Tumor necrosis factor- TRIF TIR-domain-containing adapter-inducing interferon- UKPDS United Kingdom Prospective Diabetes Study VLDL Very low-density lipoprotein Author contributions MR performed literature search
